The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia

Pediatric pharmacology
Pediatričeskaâ farmakologiâ

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

eng | рус

Pediatric pharmacology

Advanced search

The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia. Pediatric pharmacology. 2023;20(5):523. (In Russ.)

Views PDF (Rus): 102

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?